Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ÜŬ·ÐÇ×ü¸¦ ÀÌ¿ëÇÑ B¼¼Æ÷ ÀÚ°¡¼ºÀåÀÎÀÚÀÇ Æ¯Â¡ Characterization of B Cell Autocrine Growth Factor using Monoclonal Antibody

´ëÇѸ鿪ÇÐȸÁö 1995³â 17±Ç 4È£ p.317 ~ 327
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÇ屸/Hern Ku Lee ¹ÚÀç½Â/±è¼º±¤/ÇÏ´ëÀ¯/Àå¿ë¼®/Jae Seung Park/Sung Kwang Kim/Tai You Ha/Yong Suk Jang

Abstract

Á¤»ó B ¼¼Æ÷À¯·¡ ÀÚ°¡¼º ÀåÀÎÀÚ (B cell-derived B cell growth factor; B-BCGF)´Â Á¸Àç
¸¸ È®ÀεǾúÀ» »Ó ±× ºÐÀÚÀû Ư¼ºÀ̳ª »ý¹°ÇÐÀû ±â´É¿¡ °üÇؼ­´Â ÀüÇô ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù.
µû¶ó¼­ º» ¿¬±¸¿¡¼­´Â ÀÌ ¹°ÁúÀÇ º»Ã¼¸¦ ¿¬±¸ÇÏ·Á´Â ¸ñÀûÀÇ ÀÏȯÀ¸·Î B-BCGF¿¡ ´ëÇÑ ´Ü
Ŭ·Ð Ç×üÀÇ °³¹ßÀ» ½ÃµµÇÏ¿´´Ù. B-BCGF·Î´Â Staphylococcus aureus Cowan I Strain
(SAC, 0.002%) À¸·Î 24½Ã°£ ÀÚ±ØÇÑ ¹è¾ç¾×(SAC-sup)À» »ç¿ëÇÏ¿´´Ù. ³óÃàÇÑ SAC-supÀ» ¸¶
¿ì½º ºñÀå¿¡ ÁÖ»ç ¸é¿ªÇÏ¿© ¾òÀº ´ÜŬ·Ð Ç×ü´Â SAC À¸·Î ÀÚ±ØÇÑ B ¼¼Æ÷ Áõ½ÄÀ» ¾ïÁ¦ÇÏ°í
SAC-supÀ¸·Î ºÎÅÍ BCGFÈ°¼ºÀ» °¡Áø 64Kda ÀÎ ¹°ÁúÀ» ħÀü ½ÃÄ×´Ù. ÀÌ Ç×ü¸¦ ÀÌ¿ëÇÑ
affinity Å©·Î¸¶Åä±×¶óÇÇ·Î Á¤Á¦µÈ BCGF ´Â ±× ¾çÀÌ ³Ê¹« ÀÛ¾Æ ¿°±â¼­¿­À» °áÁ¤Çϴµ¥ ½Ç
ÆÐÇÏ¿´´Ù. À̵é Ç×ü ¶Ç´Â Ç×-IgM Ç×ü +IL2·Î ÀÚ±ØÇÑ B ¼¼Æ÷ÀÇ Áõ½ÄÀº ¾ïÁ¦ÇÏÁö ¸øÇÏ¿©
SACƯÀÌÀûÀÎ ±â´ÉÀ» ³ªÅ¸³»¾úÀ¸¸ç IsM Ç×ü »ý»êÀ¸·Î ¾Ë¾Æº» B ¼¼Æ÷ºÐÈ­ ¿ª½Ã 40-50%
À¯ÀÇÇÏ°Ô ¾ïÁ¦ÇÏ¿´À¸³ª È°¼ºÈ­ÀÇ ÁöÇ¥ÀÎ CD23¹× CD25ÀÇ ¹ßÇö¿¡´Â º°´Ù¸¥ ¿µÇâÀ» ¹ÌÄ¡Áö
¸øÇÏ¿´´Ù.
#ÃÊ·Ï#
It has been reported that malignant B cell line or Epstein Barr virus transformed as
well as normal B cells are capable of producing an autocrine B cell growth factor
(B-BCGF). However, the molecular nature and biological roles of B-BCGF were poorly
understood. To inverstigate this issue, we have tried to develop monoclonal
antibodies(mAbs) to B-BCGF. The purified tonsillar B cells were stimulated with
Staphylococcus aureus Cowan I strain (SAC). The 24h culture supematant(SAC-sup)
was used as the source of B-BCGF. The mice were immunized by injection of
concentrated SAC-sup via spleen. Five hybridomas which inhibited SAC-stimulated B
cell proliferation and removed B-BCGF activity from SAC-sup were selected, cloned and
mAbs were prepared as ascites from. SAC-sup which eluated from affinity column
conjugated with the mAbs(HJ 93 and HI 205) were found to have BCGF
activity,indicating that these mAbs are specific for B-BCGF of SAC-sup. The mAb,HJ
93, precipitated the molecule with M.W of 64KDa which had BCGF activity.The mAb
did not affect the expression of CD23 or CD25 which are known as activation markers
of B cells, but significantly inhibited SAC-or SAC+IL2-stimulated B cell proliferation as
well as IgM secretion from SAC+IL-2-stimulated B cells.Taken together. these data
indicated that a mAb capable of binding to 64KDa B-BCGF and inhibiting
SAC-stimulated B-cell proliferation as well as differentiation was developed.

Å°¿öµå

Autocrine B cell growth factor; monoclonal antibody.;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS